HOSE:NVL 21 February 2026

Vietnam stocks reopen after Tet: VN-Index at 1,824 puts 1,850 level in play next week

Vietnam’s VN-Index closed up 0.55% at 1,824.09 before the Tet holiday, ending a three-week losing streak. Ho Chi Minh Stock Exchange trading resumes Monday, Feb. 23. Brokers expect volatile action, with focus on foreign flows and big-cap stocks. Turnover in the last session reached nearly 20.1 trillion dong, with foreign investors net buyers by 196 billion dong.

21 February 2026

HOSE:BID·HOSE:BVH·HOSE:FPT·HOSE:MBB·HOSE:NVL·Stock Market

Telix Pharmaceuticals Names David Gill to Board, Signals Governance Shift Amid Growth Focus
April 5, 2026, 5:29 PM EDT. Telix Pharmaceuticals (ASX:TLX) appointed David Gill as a Non-Executive Director, set to succeed Dr. Mark Nelson as Chair in May 2026. Gill brings deep radiopharmaceutical and governance expertise, potentially reshaping Telix's strategy balancing growth and oversight. The company's core growth hinges on regulatory and commercial progress of pipeline assets like Pixclara and TLX591-Tx, with heavy R&D and manufacturing investment pressuring near-term earnings. The recent resubmission of TLX101-Px (Pixclara) for FDA approval is a key catalyst. Analysts' forecasts vary widely, with consensus projecting A$1.2 billion revenue and A$111.3 million earnings by 2029, but some cautioning on execution risks. The board change may influence how Telix navigates its development pipeline and investor expectations in the years ahead.